Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Anthrax immune globulin - Emergent BioSolutions (Cangene)

Drug Profile

Anthrax immune globulin - Emergent BioSolutions (Cangene)

Alternative Names: AIGIV; Anthrasil; Anthrax immune globulin - Cangene; Anthrax immune globulin intravenous; NP-015

Latest Information Update: 04 Dec 2015

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Cangene Corporation
  • Developer Emergent BioSolutions
  • Class Antibacterials; Immunoglobulins; Polyclonal antibodies
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Anthrax
  • New Molecular Entity No

Highest Development Phases

  • Marketed Anthrax

Most Recent Events

  • 31 Aug 2015 Launched for Anthrax (Combination therapy) in USA (IV)
  • 24 Mar 2015 Registered for Anthrax (Combination therapy) in USA (IV)
  • 07 Aug 2014 Preregistration for Anthrax in USA (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top